Jefferies Group LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Sep 21, 2023	BUY	$13.01 - $27.22 $27,321 - $57,162	2,100 Added 20.19%	12,500 $176,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $162,625 - $340,250	12,500 New	12,500 $176,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $201,759 - $285,168	-10,400 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$25.02 - $54.99 $260,208 - $571,896	10,400 New	10,400 $268,000
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $260,208 - $571,896	10,400 New	10,400 $268,000
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $436,760 - $699,060	-30,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $397,415 - $665,205	30,500 New	30,500 $633,000
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $505,575 - $727,425	-22,500 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $139,568 - $203,528	-5,200 Reduced 18.77%	22,500 $677,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $816,873 - $1.06 Million	27,700	27,700 $1.04 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.